Αποτελέσματα Αναζήτησης
Recent reviews show that an increased ratio of omega-6 to omega-3 fatty acids contributes to obesity rates by increasing levels of the endocannabinoid signals AEA and 2-AG, overstimulating CB 1 R and leading to increased caloric intake, reduced metabolic rates, and weight gain.
8 Νοε 2023 · Cannabinoid-based pharmaceuticals vs. diet as tools for weight loss & metabolic health. If chronic cannabis stimulation of CB1 receptors leads to weight gain, shouldn’t drugs with the opposite...
Cannabidiol (CBD) and Δ-9-tetrahydrocannabinol (THC) in cannabis possess nutritional and therapeutic benefits against chronic pain, anxiety, vomiting, and weight loss. Chronic use of CBD and especially, THC, is associated with health risks, including physiological, psychiatric, addiction, and dependency issues.
12 Σεπ 2024 · As already established, cannabis-infused products offer a range of therapeutic benefits due to the presence of cannabinoids, such as THC and CBD, and other compounds found in the cannabis plant (Figure 6). The therapeutic advantages of cannabis-infused products have been widely discussed to include both cannabinoids and non-cannabinoid-based ...
19 Φεβ 2020 · Animal and human research suggest that increased activity of the endocannabinoid system may lead to insulin resistance, glucose intolerance, and obesity. Accordingly, CB 1 receptor...
The way that cannabis may affect weight loss is through the cannabinoid THCV. In low to moderate doses, THCV may block CB1 receptors in the brain that control appetite. But in higher doses, THCV is psychoactive and could have some of the same effects as THC, including appetite stimulation.
Background and objective: Cannabidiol, one of the main components of the Cannabis sativa plant, is a non-psychotropic cannabinoid that has recently drawn the attention of researchers and clinicians for its potential therapeutic applications.
